@https://claude.ai/artifact/1j4bEdW88WobT7smoMLvwt make presentation on newer drugs for atopic dermatitis based on this reveiw and pubmed publications faers tinetx, chohorts, case series, explain correlation of ad and mycosis fungoides ctcl, explain prevalence of mycosis fungoides in atopic dermatitis, expalin different new drugs and their cuasality to mycosis fungoides, dupilumab, il13, jak1,2, jak1,3 all jaks, neolizumab ,and make a presentation with the new drugs and mycoss fungoides
@https://claude.ai/artifact/1j4bEdW88WobT7smoMLvwt make presentation on newer drugs for atopic dermatitis based on this reveiw and pubmed publications faers tinetx, chohorts, case series, explain correlation of ad and mycosis fungoides ctcl, explain prevalence of mycosis fungoides in atopic dermatitis, expalin different new drugs and their cuasality to mycosis fungoides, dupilumab, il13, jak1,2, jak1,3 all jaks, neolizumab ,and make a presentation with the new drugs and mycoss fungoides
Created using ChatSlide
This overview explores the intersection of Atopic Dermatitis (AD) and Mycosis Fungoides (MF), detailing their overlap and epidemiological signals. It quantifies MF prevalence in AD patients and highlights diagnostic challenges. The discussion extends to new therapies, comparing treatments like dupilumab and JAK inhibitors while analyzing data from various sources. Clinical cases illustrate the complexities of diagnosing coexisting conditions, emphasizing the importance of biopsy and...